Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy
ABOUT THIS EPISODE
Originally aired: May 1, 2024
CHEST May 2024, Volume 165, Issue 5
Janani S. Reisenauer, MD; Patrick W. Eiken, MD; and Dawn Owen, MD, PhD, join CHEST® Journal Podcast Moderator, Dominique Pepper, MD, to discuss new research comparing outcomes for metastasis-directed therapies, including sublobar resection, stereotactic body radiation therapy, and percutaneous ablation.
READ THE ARTICLE »
Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.
Moderator
Dominique Pepper, MD